Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

Scientists Testing SARS Drug

From U.S. Centers for Disease Control and Prevention

May 12, 2003

At a news conference in Hong Kong Sunday, pioneering AIDS researcher Dr. David Ho said he is collaborating with scientists in China to develop a drug to control severe acute respiratory syndrome (SARS). The scientists are testing a synthetic protein inhibitor, or peptide, that aims to block the SARS virus from penetrating human cells. The approach used by Ho, of the Aaron Diamond AIDS Research Center at Rockefeller University in New York, and scientists from the University of Hong Kong is adapted from a drug used to fight HIV. Microbiologist Malik Peiris of the University of Hong Kong said some signatures in the SARS virus are similar to HIV. Ho said the peptide proved successful in preventing the SARS virus from entering cultured cells in initial tests, but more work is needed before a drug can be made available commercially.

Back to other CDC news for May 12, 2003

Previous Updates

Adapted from:
Washington Post
05.12.03; Reuters


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
 
See Also
More on SARS and HIV/AIDS

Tools
 

Advertisement